O

OmniAb Inc
NASDAQ:OABI

Watchlist Manager
OmniAb Inc
NASDAQ:OABI
Watchlist
Price: 3.92 USD 1.82% Market Closed
Market Cap: 463.2m USD
Have any thoughts about
OmniAb Inc?
Write Note

OmniAb Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OmniAb Inc
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
O
OmniAb Inc
NASDAQ:OABI
Tax Provision
$13.7m
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Tax Provision
-$641m
CAGR 3-Years
21%
CAGR 5-Years
-8%
CAGR 10-Years
-8%
Danaher Corp
NYSE:DHR
Tax Provision
-$504m
CAGR 3-Years
26%
CAGR 5-Years
9%
CAGR 10-Years
4%
Mettler-Toledo International Inc
NYSE:MTD
Tax Provision
-$159.6m
CAGR 3-Years
4%
CAGR 5-Years
-5%
CAGR 10-Years
-4%
Agilent Technologies Inc
NYSE:A
Tax Provision
-$127m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
-45%
IQVIA Holdings Inc
NYSE:IQV
Tax Provision
-$87m
CAGR 3-Years
20%
CAGR 5-Years
0%
CAGR 10-Years
5%
No Stocks Found

OmniAb Inc
Glance View

Market Cap
471.3m USD
Industry
Life Sciences Tools & Services

OmniAb, Inc. operates as a drug discovery company. The company is headquartered in Emeryville, California and currently employs 93 full-time employees. The company went IPO on 2020-10-09. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to generate antibodies with human sequences to facilitate the development of human therapeutic candidates. Its OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications through a common light chain approach and OmniTaur features structural attributes of cow antibodies for complex targets. The firm's OmniChicken and OmniClic offer affinity-matured antibodies in an evolutionarily distant chicken host environment, which can deliver a diverse repertoire of antibody panels to conserved therapeutic targets.

OABI Intrinsic Value
4.35 USD
Undervaluation 10%
Intrinsic Value
Price
O

See Also

What is OmniAb Inc's Tax Provision?
Tax Provision
13.7m USD

Based on the financial report for Dec 31, 2023, OmniAb Inc's Tax Provision amounts to 13.7m USD.

What is OmniAb Inc's Tax Provision growth rate?
Tax Provision CAGR 3Y
31%

Over the last year, the Tax Provision growth was 268%. The average annual Tax Provision growth rates for OmniAb Inc have been 31% over the past three years .

Back to Top